tiprankstipranks
Tvardi Therapeutics (DE:69C)
FRANKFURT:69C

Tvardi Therapeutics (69C) Revenue

1 Followers

Tvardi Therapeutics Revenue

Tvardi Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Increased -100.00%. In the fiscal year ending Mar 31, 2026, Tvardi Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
0.00
Revenue Growth
-100.00%
P/S Ratio
Revenue/Employee
€0
Employees
12
Market Cap
€21.90M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2026
-7.14M-100.00%
Dec 31, 2024
7.14M-13.83M-65.96%
Dec 31, 2023
20.97M-20.90M-49.92%
Dec 31, 2022
41.87M18.84M+81.81%
Dec 31, 2021
23.03M-112.05M-82.95%
Dec 31, 2020
135.08M115.20M+579.28%
Dec 31, 2019
19.89M6.42M+47.64%
Dec 31, 2018
13.47M12.56M+1,378.49%
Dec 31, 2017
911.00K